Bioreactor technologies are being developed to enable bone, cartilage, tendon and skin culture to grow, whilst the ultimate aim is bulky tissue growth from stem cell cultures and the development of online monitoring techniques that use micro-membrane probes, microsensors, and multiphoton microscopy for monitoring cell metabolism and functions, tissue formation, and stem cell differentiation. A further area of interest is the study of the technology and underlining science in cryopreservation and vitrification to preserve living cells and engineered tissues, in order to ensure their off-the-shelf availability to clinicians. Finally, techniques are also being developed to enable the use of stem cells for drug and toxicology testing.
This work is being carried out in collaboration with the China Regenerative Medicine International (CRMI).: a long-term partnership between Oxford University and